Please see the attached updated MedImpact Commercial Payer Sheet. This reflects new BIN: 006631.

• The prescriber is valid and active and authorized by state and federal regulatory agencies to prescribe medications 
• The prescriber has a Type 1 NPI which must be submitted on the prescription claim. No other form of prescriber identification will be accepted. Any claim submitted with an invalid NPI will reject, but the appropriate SCC value can be used to override the rejection. This requirement is being applied to all claims since most health care providers are required to obtain and use an NPI as a standard identifier.  
• For controlled substance prescribing, a prescriber must have an active DEA identifier in good standing and have the authority to prescribe a controlled substance in a given DEA drug class schedule (2,2N,3,3N,4,5), but the appropriate SCC value can be used to override the rejection.

OPUS Health would like to inform you of the following new Copay Assistance Program(s) (see list below). This new program can be viewed on the OPUS Health Pharmacy Portal. Please use the link below to log in and select View New or Modified Programs to view the new program. If you have already created an account, use the email address and password you created to log in. If you do not have an account, please click on the link below and select Create Account to register. Registering takes just a minute or two and provides access to this and all active programs ? even some printable offers you can provide for your pharmacy customers.

New Announcements:

·  Crown Laboratories Copay Savings Program OH2201031, OH2201041, OH2201051.

·  Sebela Naftin Copay Program OH2301011, OH2301021.

·  Sebela Onmel Copay Program OH2302011, OH2302021.

·  HLS Therapeutics Clozaril Copay Program OH2101011, OH2101021.

·  Arthrotec Copay Program OH7708211, OH7708221, OH7708231, OH7708241.

·  Caverject Copay Program OH7705011.

http://www.opushealth.com/pharmacyPortal/index.aspx